Ripped Injectable (RAD-140 + S-23) 

Description

Ripped Injectable (RAD-140 + S-23)

• Ripped injectable consists of 35mg RAD-140 and 35mg S-23.
• Ripped is offered in 70mg per ml for 10ml, totaling 700mg.

RAD-140 (Testolone)

Testolone, often referred to as RAD 140, is currently under thorough investigation as a research compound, with a specific focus on its potential to augment muscle hypertrophy. Ongoing studies delve into the preclinical characterization of selective androgen receptor modulators, emphasizing their anabolic activity in male cynomolgus monkeys. A key metric under scrutiny to assess anabolic activity is gross body weight, recognized as a sensitive indicator of anabolic androgen action in young nonhuman primates. The outcomes of a study involving a 28-day dosing regimen with RAD140 revealed statistically significant changes in animal body weight, signaling substantial promise in the potential for muscular gains attributed to Testolone. These findings contribute to the evolving understanding of RAD 140’s impact on muscle development, paving the way for further exploration and potential applications in the field of muscle enhancement research.

RAD-140
CAS Number	1182367-47-0
Molar Mass	393.83 g·mol−1
Chemical Formula	C20H16ClN5O2
IUPAC Name	2-chloro-4-{[(1R,2S)-1-[5-(4-cyanophenyl)-1,3,4-oxadiazol-2-yl]-2-hydroxypropyl]amino}-3-methylbenzonitrile

S-23

S23 is a type of selective androgen receptor modulator (SARM), a class of compounds designed to selectively target and interact with androgen receptors in the body.

Based on existing studies, the S23 SARM has demonstrated the induction of temporary infertility in all rats exposed to it, with the effects being dose-dependent. Notably, fertility was restored in the rats post-treatment, suggesting the potential of S23 as an oral male contraceptive. The research underscores S23’s impact on reproductive hormones, specifically subduing serum concentrations of luteinizing hormone and follicle-stimulating hormone, resulting in biphasic effects on spermatogenesis. While the findings provide intriguing insights into S23’s contraceptive potential, further research and clinical trials are imperative to establish its efficacy and safety as an oral contraceptive.

Beyond its contraceptive effects, the study revealed additional positive outcomes. Notably, S23 exhibited a stronger affinity to androgen receptors compared to popular compounds like Andarine, presenting an advantageous characteristic. Its favorable anabolic-androgenic ratio positions it as a compound capable of generating positive effects without severe complications. Among these effects, S23 showcased the ability to increase bone mineral density and promote lean muscle mass.

Consequently, while S23 holds promise as a potential male birth control pill, its versatility extends to other research purposes. Particularly, its exploration among subjects with chronic conditions leading to muscle wasting could unveil additional therapeutic applications. This highlights the multifaceted nature of S23, warranting continued investigation for its diverse physiological effects and potential clinical applications.

S-23
CAS Number	1010396-29-8
Molar Mass	416.76 g·mol−1
Chemical Formula	C18H13ClF4N2O3
IUPAC Name	(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide